Advertisement

Hepatitis B surface antigen quantification: Not what it seems on the surface

Authors


  • Potential conflict of interest: Dr. Locarnini consults for and received fees from Bristol-Myers Squibb. He received royalties from and holds intellectual property rights with Melbourne Health. He consults for Gilead. He received fees from Merck.

Ancillary